Clozapine-related tachycardia: A conundrum to identify and treat.

Dermot BrennanSweta LalFrans HugoFlavie WatersGordon Shymko

Published in: Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists (2024)

The cardiovascular risks of clozapine are often overlooked. β-blockers are useful in lowering heart rates but they may be insufficient to reduce cardiac risk.

Keyphrases

heart failure
left ventricular
angiotensin converting enzyme
human health
atrial fibrillation
risk assessment
angiotensin ii